The cell wall architecture of Enterococcus faecium: from resistance to pathogenesis

Future Microbiology

Volumn 8, Issue 8, 2013, Pages 993-1010

  Hendrickx, Antoni P A ^a,b   Van Schaik, Willem ^a   Willems, Rob J L ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b UNIVERSITY OF CHICAGO   (United States)

Author keywords

antibiotics; capsular polysaccharides; cell wall; E. faecium; lipoteichoic acid; LPxTG surface proteins; pili; resistance; wall teichoic acid; WxL

Indexed keywords

BACTERIAL POLYSACCHARIDE; DAPTOMYCIN; LIPOTEICHOIC ACID; MYELOID DIFFERENTIATION FACTOR 88; PENICILLIN BINDING PROTEIN 5; PEPTIDOGLYCAN; TEICHOIC ACID; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 9;

AMINO ACID SEQUENCE; AMINO TERMINAL SEQUENCE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC THERAPY; BACTERIAL CELL WALL; BACTERIAL COLONIZATION; BACTERIAL GROWTH; BACTERIAL VIRULENCE; BACTERIUM ISOLATE; BIOGENESIS; CARBOXY TERMINAL SEQUENCE; CELL DIVISION; CONFORMATIONAL TRANSITION; COVALENT BOND; CRYSTAL STRUCTURE; DNA BASE COMPOSITION; ENTEROCOCCAL INFECTION; ENTEROCOCCUS FAECIUM; EXTRACELLULAR MATRIX; HUMAN; HYDROGEN BOND; LIGAND BINDING; LIPID BILAYER; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PASSIVE IMMUNIZATION; PENICILLIN RESISTANCE; POINT MUTATION; PRIORITY JOURNAL; REVIEW;

ANIMALS; BACTERIAL PROTEINS; CELL WALL; CROSS INFECTION; DRUG RESISTANCE, BACTERIAL; ENTEROCOCCUS FAECIUM; FIMBRIAE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; LIPOPOLYSACCHARIDES; MAMMALS; MEMBRANE PROTEINS; PEPTIDOGLYCAN; POLYSACCHARIDES, BACTERIAL; TEICHOIC ACIDS; VIRULENCE FACTORS;

EID: 84881269813     PISSN: 17460913     EISSN: 17460921     Source Type: Journal    
DOI: 10.2217/fmb.13.66     Document Type: Review

References (156)

1. Sghir A, Gramet G, Suau A, Rochet V, Pochart P, Dore J. Quantification of bacterial groups within human fecal flora by oligonucleotide probe hybridization. Appl. Environ. Microbiol. 66 (5), 2263-2266 (2000).
2. Murray BE. The life and times of the Enterococcus. Clin. Microbiol. Rev. 3 (1), 46-65 (1990).
3. Hooper LV, Littman DR, Macpherson AJ. Interactions between the microbiota and the immune system. Science 336 (6086), 1268-1273 (2012).
4. Booijink CC, El-Aidy S, Rajilic-Stojanovic M et al. High temporal and inter-individual variation detected in the human ileal microbiota. Environ. Microbiol. 12 (12), 3213-3227 (2010).
5. Hayashi H, Takahashi R, Nishi T, Sakamoto M, Benno Y. Molecular analysis of jejunal, ileal, caecal and recto-sigmoidal human colonic microbiota using 16S rRNA gene libraries and terminal restriction fragment length polymorphism. J. Med. Microbiol. 54 (Pt 11), 1093-1101 (2005).
6. MacCallum WG, Hastings TW. A case of acute endocarditis caused by Micrococcus zymogenes (nov. spec.), with a description of the microorganism. J. Exp. Med. 4 (5-6), 521-534 (1899).
7. Leclercq R, Derlot E, Duval J, Courvalin P. Plasmid-mediated resistance to vancomycin and teicoplanin in Enterococcus faecium. N. Engl. J. Med. 319 (3), 157-161 (1988).
8. Uttley AH, Collins CH, Naidoo J, George RC. Vancomycin-resistant enterococci. Lancet 1 (8575-8576), 57-58 (1988).
9. Arias CA, Murray BE. The rise of the Enterococcus: Beyond vancomycin resistance. Nat. Rev. Microbiol. 10 (4), 266-278 (2012).
10. Hidron AI, Edwards JR, Patel J et al.; National Healthcare Safety Network Team; Participating National Healthcare Safety Network Facilities. NHSN annual update: Antimicrobial-resistant pathogens associated with healthcare-associated infections: Annual summary of data reported to the National Healthcare Safety Network at the Centers for Disease Control and Prevention, 2006-2007. Infect. Control Hosp. Epidemiol. 29 (11), 996-1011 (2008).
11. Werner G, Coque TM, Hammerum AM et al. Emergence and spread of vancomycin resistance among enterococci in Europe. Euro Surveill. 13 (47), 19046 (2008).
12. Gordon S, Swenson JM, Hill BC et al. Antimicrobial susceptibility patterns of common and unusual species of enterococci causing infections in the United States. Enterococcal Study Group. J. Clin. Microbiol. 30 (9), 2373-2378 (1992).
13. Iwen PC, Kelly DM, Linder J et al. Change in prevalence and antibiotic resistance of Enterococcus species isolated from blood cultures over an 8-year period. Antimicrob. Agents Chemother. 41 (2), 494-495 (1997).
14. Low DE, Keller N, Barth A, Jones RN. Clinical prevalence, antimicrobial susceptibility, and geographic resistance patterns of enterococci: Results from the SENTRY Antimicrobial Surveillance Program, 1997-1999. Clin. Infect. Dis. 32 (Suppl. 2), S133-S145 (2001).
15. Mundy LM, Sahm DF, Gilmore M. Relationships between enterococcal virulence and antimicrobial resistance. Clin. Microbiol. Rev. 13 (4), 513-522 (2000).
16. Top J, Willems R, Blok H et al. Ecological replacement of Enterococcus faecalis by multiresistant clonal complex 17 Enterococcus faecium. Clin. Microbiol. Infect. 13 (3), 316-319 (2007).
17. Treitman AN, Yarnold PR, Warren J, Noskin GA. Emerging incidence of Enterococcus faecium among hospital isolates (1993 to 2002). J. Clin. Microbiol. 43 (1), 462-463 (2005).
18. Arias CA, Murray BE. Emergence and management of drug-resistant enterococcal infections. Expert Rev. Anti Infect. Ther. 6 (5), 637-655 (2008).
19. Arias CA, Mendes RE, Stilwell MG, Jones RN, Murray BE. Unmet needs and prospects for oritavancin in the management of vancomycin-resistant enterococcal infections. Clin. Infect. Dis. 54 (Suppl. 3), S233-S238 (2012).
20. Murdoch DR, Mirrett S, Harrell LJ, Monahan JS, Reller LB. Sequential emergence of antibiotic resistance in enterococcal bloodstream isolates over 25 years. Antimicrob. Agents Chemother. 46 (11), 3676-3678 (2002).
21. Hendrickx AP, van Wamel WJ, Posthuma G, Bonten MJ, Willems RJ. Five genes encoding surface-exposed LPXTG proteins are enriched in hospital-adapted Enterococcus faecium clonal complex 17 isolates. J. Bacteriol. 189 (22), 8321-8332 (2007).
22. Leavis HL, Willems RJ, van Wamel WJ, Schuren FH, Caspers MP, Bonten MJ. Insertion sequence-driven diversification creates a globally dispersed emerging multiresistant subspecies of E. faecium. PLoS Pathog. 3 (1), e7 (2007).
23. van Schaik W, Top J, Riley DR et al. Pyrosequencing-based comparative genome analysis of the nosocomial pathogen Enterococcus faecium and identification of a large transferable pathogenicity island. BMC Genomics 11, 239 (2010).
24. van Schaik W, Willems RJ. Genome-based insights into the evolution of enterococci. Clin. Microbiol. Infect. 16 (6), 527-532 (2010).
25. Willems RJ, Homan W, Top J et al. Variant esp gene as a marker of a distinct genetic lineage of vancomycin-resistant Enterococcus faecium spreading in hospitals. Lancet 357 (9259), 853-855 (2001).
26. Zhang X, Vrijenhoek JE, Bonten MJ, Willems RJ, van Schaik W. A genetic element present on megaplasmids allows Enterococcus faecium to use raffinose as carbon source. Environ. Microbiol. 13 (2), 518-528 (2011).
27. Hendrickx AP, Bonten MJ, van Luit-Asbroek M, Schapendonk CM, Kragten AH, Willems RJ. Expression of two distinct types of pili by a hospital-acquired Enterococcus faecium isolate. Microbiology 154 (Pt 10), 3212-3223 (2008).
28. Hendrickx AP, van Luit-Asbroek M, Schapendonk CM et al. SgrA, a nidogen-binding LPXTG surface adhesin implicated in biofilm formation, and EcbA, a collagen binding MSCRAMM, are two novel adhesins of hospital-acquired Enterococcus faecium. Infect. Immun. 77 (11), 5097-5106 (2009).
29. Leavis H, Top J, Shankar N et al. A novel putative enterococcal pathogenicity island linked to the esp virulence gene of Enterococcus faecium and associated with epidemicity. J. Bacteriol. 186 (3), 672-682 (2004).
30. Willems RJ, Top J, van Schaik W et al. Restricted gene flow among hospital subpopulations of Enterococcus faecium. MBio 3 (4), e00151-12 (2012).
31. Willems RJ, van Schaik W. Transition of Enterococcus faecium from commensal organism to nosocomial pathogen. Future Microbiol. 4 (9), 1125-1135 (2009).
32. Willems RJ, Hanage WP, Bessen DE, Feil EJ. Population biology of Gram-positive pathogens: High-risk clones for dissemination of antibiotic resistance. FEMS Microbiol. Rev. 35 (5), 872-900 (2011).
33. Schneewind O, Missiakas DM. Protein secretion and surface display in Gram-positive bacteria. Philos. Trans. R. Soc. Lond. B Biol. Sci. 367 (1592), 1123-1139 (2012).
34. Reffuveille F, Leneveu C, Chevalier S, Auffray Y, Rince A. Lipoproteins of Enterococcus faecalis: Bioinformatic identification, expression analysis and relation to virulence. Microbiology 157 (Pt 11), 3001-3013 (2011).
35. Eckert C, Lecerf M, Dubost L, Arthur M, Mesnage S. Functional analysis of AtlA, the major N-acetylglucosaminidase of Enterococcus faecalis. J. Bacteriol. 188 (24), 8513-8519 (2006).
36. Artis D. Epithelial-cell recognition of commensal bacteria and maintenance of immune homeostasis in the gut. Nat. Rev. Immunol. 8 (6), 411-420 (2008).
37. Vaishnava S, Yamamoto M, Severson KM et al. The antibacterial lectin RegIIIg promotes the spatial segregation of microbiota and host in the intestine. Science 334 (6053), 255-258 (2011).
38. Ivanov II, Littman DR. Modulation of immune homeostasis by commensal bacteria. Curr. Opin. Microbiol. 14 (1), 106-114 (2011).
39. Akira S, Uematsu S, Takeuchi O. Pathogen recognition and innate immunity. Cell 124 (4), 783-801 (2006).
40. Beutler B, Jiang Z, Georgel P et al. Genetic analysis of host resistance: Toll-like receptor signaling and immunity at large. Annu. Rev. Immunol. 24, 353-389 (2006).
41. Donskey CJ, Chowdhry TK, Hecker MT et al. Effect of antibiotic therapy on the density of vancomycin-resistant enterococci in the stool of colonized patients. N. Engl. J. Med. 343 (26), 1925-1932 (2000).
42. Ruiz-Garbajosa P, de Regt M, Bonten M et al. High-density fecal Enterococcus faecium colonization in hospitalized patients is associated with the presence of the polyclonal subcluster CC17. Eur. J. Clin. Microbiol. Infect. Dis. 31 (4), 519-522 (2012).
43. Zhang X, Top J, de Been M et al. Identification of a genetic determinant in clinical Enterococcus faecium strains that contributes to intestinal colonization during antibiotic treatment. J. Infect. Dis. 207 (11), 1780-1786 (2013).
44. Brandl K, Plitas G, Mihu CN et al. Vancomycin-resistant enterococci exploit antibiotic-induced innate immune deficits. Nature 455 (7214), 804-807 (2008).
45. Cash HL, Whitham CV, Behrendt CL, Hooper LV. Symbiotic bacteria direct expression of an intestinal bactericidal lectin. Science 313 (5790), 1126-1130 (2006).
46. Ubeda C, Taur Y, Jenq RR et al. Vancomycin-resistant Enterococcus domination of intestinal microbiota is enabled by antibiotic treatment in mice and precedes bloodstream invasion in humans. J. Clin. Invest. 120 (12), 4332-4341 (2010).
47. Taur Y, Xavier JB, Lipuma L et al. Intestinal domination and the risk of bacteremia in patients undergoing allogeneic hematopoietic stem cell transplantation. Clin. Infect. Dis. 55 (7), 905-914 (2012).
48. Leendertse M, Willems RJ, Oei GA, Florquin S, Bonten MJ, van der PT. Intestinal Enterococcus faecium colonization improves host defense during polymicrobial peritonitis. J. Infect. Dis. 200 (5), 735-744 (2009).
49. Lovering AL, Safadi SS, Strynadka NC. Structural perspective of peptidoglycan biosynthesis and assembly. Annu. Rev. Biochem. 81, 451-478 (2012).
50. Reynolds PE. Structure, biochemistry and mechanism of action of glycopeptide antibiotics. Eur. J. Clin. Microbiol. Infect. Dis. 8 (11), 943-950 (1989).
51. Park JT, Strominger JL. Mode of action of penicillin. Science 125 (3238), 99-101 (1957).
52. Higashi Y, Strominger JL, Sweeley CC. Structure of a lipid intermediate in cell wall peptidoglycan synthesis: A derivative of a C55 isoprenoid alcohol. Proc. Natl Acad. Sci. USA 57 (6), 1878-1884 (1967).
53. Anderson JS, Matsuhashi M, Haskin MA, Strominger JL. Lipid- phosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: Presumed membrane transport intermediates in cell wall synthesis. Proc. Natl Acad. Sci. USA 53, 881-889 (1965).
54. Strominger JL. Penicillin-sensitive enzymatic reactions in bacterial cell wall synthesis. Harvey Lect. 64, 179-213 (1968).
55. Tipper DJ, Strominger JL. Mechanism of action of penicillins: A proposal based on their structural similarity to acyl-d-alanyl-d-alanine. Proc. Natl Acad. Sci. USA 54 (4), 1133-1141 (1965).
56. Staudenbauer W, Willoughby E, Strominger JL. Further studies of the d-aspartic acid-activating enzyme of Streptococcus faecalis and its attachment to the membrane. J. Biol. Chem. 247 (17), 5289-5296 (1972).
57. Hollenbeck BL, Rice LB. Intrinsic and acquired resistance mechanisms in enterococcus. Virulence 3 (5), 421-433 (2012).
58. Canton R, Ruiz-Garbajosa P, Chaves RL, Johnson AP. A potential role for daptomycin in enterococcal infections: What is the evidence? J. Antimicrob. Chemother. 65 (6), 1126-1136 (2010).
59. Poutsiaka DD, Skiffington S, Miller KB, Hadley S, Snydman DR. Daptomycin in the treatment of vancomycin-resistant Enterococcus faecium bacteremia in neutropenic patients. J. Infect. 54 (6), 567-571 (2007).
60. Rice LB. Mechanisms of resistance and clinical relevance of resistance to b lactams, glycopeptides, and fluoroquinolones. Mayo Clin. Proc. 87 (2), 198-208 (2012).
61. Arthur M, Courvalin P. Genetics and mechanisms of glycopeptide resistance in enterococci. Antimicrob. Agents Chemother. 37 (8), 1563-1571 (1993).
62. Werner G, Strommenger B, Witte W. Acquired vancomycin resistance in clinically relevant pathogens. Future Microbiol. 3 (5), 547-562 (2008).
63. Arthur M, Molinas C, Depardieu F, Courvalin P. Characterization of Tn1546, a Tn3-related transposon conferring glycopeptide resistance by synthesis of depsipeptide peptidoglycan precursors in Enterococcus faecium BM4147. J. Bacteriol. 175 (1), 117-127 (1993).
64. Quintiliani R Jr, Courvalin P. Characterization of Tn1547, a composite transposon flanked by the IS16 and IS256-like elements, that confers vancomycin resistance in Enterococcus faecalis BM4281. Gene 172 (1), 1-8 (1996).
65. Quintiliani R Jr, Courvalin P. Conjugal transfer of the vancomycin resistance determinant vanB between enterococci involves the movement of large genetic elements from chromosome to chromosome. FEMS Microbiol. Lett. 119 (3), 359-363 (1994).
66. Rice LB, Carias LL, Donskey CL, Rudin SD. Transferable, plasmid-mediated vanB-type glycopeptide resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 42 (4), 963-964 (1998).
67. Courvalin P. Vancomycin resistance in Gram-positive cocci. Clin. Infect. Dis. 42 (Suppl. 1), S25-S34 (2006).
68. Ghuysen JM. Serine beta-lactamases and penicillin-binding proteins. Annu. Rev. Microbiol. 45, 37-67 (1991).
69. Zapun A, Contreras-Martel C, Vernet T. Penicillin-binding proteins and b lactam resistance. FEMS Microbiol. Rev. 32 (2), 361-385 (2008).
70. Kohanski MA, Dwyer DJ, Hayete B, Lawrence CA, Collins JJ. A common mechanism of cellular death induced by bactericidal antibiotics. Cell 130 (5), 797-810 (2007).
71. Ghuysen JM. Molecular structures of penicillin-binding proteins and beta-lactamases. Trends Microbiol. 2 (10), 372-380 (1994).
72. Rice LB, Carias LL, Hutton-Thomas R, Sifaoui F, Gutmann L, Rudin SD. Penicillin-binding protein 5 and expression of ampicillin resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 45 (5), 1480-1486 (2001).
73. Sifaoui F, Arthur M, Rice L, Gutmann L. Role of penicillin-binding protein 5 in expression of ampicillin resistance and peptidoglycan structure in Enterococcus faecium. Antimicrob. Agents Chemother. 45 (9), 2594-2597 (2001).
74. Sauvage E, Kerff F, Fonze E et al. The 2.4-A crystal structure of the penicillin-resistant penicillin-binding protein PBP5fm from Enterococcus faecium in complex with benzylpenicillin. Cell. Mol. Life Sci. 59 (7), 1223-1232 (2002).
75. Galloway-Pena JR, Nallapareddy SR, Arias CA, Eliopoulos GM, Murray BE. Analysis of clonality and antibiotic resistance among early clinical isolates of Enterococcus faecium in the United States. J. Infect. Dis. 200 (10), 1566-1573 (2009).
76. Galloway-Pena JR, Rice LB, Murray BE. Analysis of PBP5 of early U.S. isolates of Enterococcus faecium: Sequence variation alone does not explain increasing ampicillin resistance over time. Antimicrob. Agents Chemother. 55 (7), 3272-3277 (2011).
77. Rice LB, Bellais S, Carias LL et al. Impact of specific pbp5 mutations on expression of b-lactam resistance in Enterococcus faecium. Antimicrob. Agents Chemother. 48 (8), 3028-3032 (2004).
78. Zhang X, Paganelli FL, Bierschenk D et al. Genome-wide identification of ampicillin resistance determinants in Enterococcus faecium. PLoS Genet. 8 (6), e1002804 (2012).
79. Mainardi JL, Fourgeaud M, Hugonnet JE et al. A novel peptidoglycan cross-linking enzyme for a b lactam-resistant transpeptidation pathway. J. Biol. Chem. 280 (46), 38146-38152 (2005).
80. Sacco E, Hugonnet JE, Josseaume N et al. Activation of the l,d-transpeptidation peptidoglycan cross-linking pathway by a metallo-d,d-carboxypeptidase in Enterococcus faecium. Mol. Microbiol. 75 (4), 874-885 (2010).
81. O'Brien MJ, Kuhl SA, Starzyk MJ. Correlation of teichoic acid d-alanyl esterification with the expression of methicillin resistance in Staphylococcus aureus. Microbios 83 (335), 119-137 (1995).
82. Farha MA, Leung A, Sewell EW et al. Inhibition of WTA synthesis blocks the cooperative action of PBPs and sensitizes MRSA to b-lactams. ACS Chem. Biol. 8 (1), 226-233 (2012).
83. Cattoir V, Leclercq R. Twenty-five years of shared life with vancomycin-resistant enterococci: Is it time to divorce? J. Antimicrob. Chemother. 68 (4), 731-742 (2012).
84. Arias CA, Panesso D, McGrath DM et al. Genetic basis for in vivo daptomycin resistance in enterococci. N. Engl. J. Med. 365 (10), 892-900 (2011).
85. Munita JM, Panesso D, Diaz L et al. Correlation between mutations in liaFSR of Enterococcus faecium and MIC of daptomycin: Revisiting daptomycin breakpoints. Antimicrob. Agents Chemother. 56 (8), 4354-4359 (2012).
86. Tran TT, Panesso D, Gao H et al. Whole-genome analysis of a daptomycin-susceptible Enterococcus faecium strain and its daptomycin-resistant variant arising during therapy. Antimicrob. Agents Chemother. 57 (1), 261-268 (2013).
87. Winkler ME, Hoch JA. Essentiality, bypass, and targeting of the YycFG (VicRK) two-component regulatory system in Gram-positive bacteria. J. Bacteriol. 190 (8), 2645-2648 (2008).
88. Dubrac S, Bisicchia P, Devine KM, Msadek T. A matter of life and death: Cell wall homeostasis and the WalKR (YycGF) essential signal transduction pathway. Mol. Microbiol. 70 (6), 1307-1322 (2008).
89. Weidenmaier C, Peschel A. Teichoic acids and related cell-wall glycopolymers in Gram-positive physiology and host interactions. Nat. Rev. Microbiol. 6 (4), 276-287 (2008).
90. Coley J, Duckworth M, Baddiley J. The occurrence of lipoteichoic acids in the membranes of Gram-positive bacteria. J. Gen. Microbiol. 73 (3), 587-591 (1972).
91. Reichmann NT, Grundling A. Location, synthesis and function of glycolipids and polyglycerolphosphate lipoteichoic acid in Gram-positive bacteria of the phylum Firmicutes. FEMS Microbiol. Lett. 319 (2), 97-105 (2011).
92. Theilacker C, Kaczynski Z, Kropec A et al. Opsonic antibodies to Enterococcus faecalis strain 12030 are directed against lipoteichoic acid. Infect. Immun. 74 (10), 5703-5712 (2006).
93. Sava IG, Heikens E, Kropec A, Theilacker C, Willems R, Huebner J. Enterococcal surface protein contributes to persistence in the host but is not a target of opsonic and protective antibodies in Enterococcus faecium infection. J. Med. Microbiol. 59 (Pt 9), 1001-1004 (2010).
94. Richter SG, Elli D, Kim HK et al. Small molecule inhibitor of lipoteichoic acid synthesis is an antibiotic for Gram-positive bacteria. Proc. Natl Acad. Sci. USA 110 (9), 3531-3536 (2013).
95. Grundling A, Schneewind O. Synthesis of glycerol phosphate lipoteichoic acid in Staphylococcus aureus. Proc. Natl Acad. Sci. USA 104 (20), 8478-8483 (2007).
96. Fabretti F, Theilacker C, Baldassarri L et al. Alanine esters of enterococcal lipoteichoic acid play a role in biofilm formation and resistance to antimicrobial peptides. Infect. Immun. 74 (7), 4164-4171 (2006).
97. Gutmann L, Al-Obeid S, Billot-Klein D, Ebnet E, Fischer W. Penicillin tolerance and modification of lipoteichoic acid associated with expression of vancomycin resistance in vanB-type Enterococcus faecium D366. Antimicrob. Agents Chemother. 40 (1), 257-259 (1996).
98. Bychowska A, Theilacker C, Czerwicka M et al. Chemical structure of wall teichoic acid isolated from Enterococcus faecium strain U0317. Carbohydr. Res. 346 (17), 2816-2819 (2011).
99. Theilacker C, Holst O, Lindner B, Huebner J, Kaczynski Z. The structure of the wall teichoic acid isolated from Enterococcus faecalis strain 12030. Carbohydr. Res. 354, 106-109 (2012).
100. Geiss-Liebisch S, Rooijakkers SH, Beczala A et al. Secondary cell wall polymers of Enterococcus faecalis are critical for resistance to complement activation via mannose-binding lectin. J. Biol. Chem. 287 (45), 37769-37777 (2012).
101. Roberts I S. The biochemistry and genetics of capsular polysaccharide production in bacteria. Annu. Rev. Microbiol. 50, 285-315 (1996).
102. Huebner J, Wang Y, Krueger WA et al. Isolation and chemical characterization of a capsular polysaccharide antigen shared by clinical isolates of Enterococcus faecalis and vancomycin-resistant Enterococcus faecium. Infect. Immun. 67 (3), 1213-1219 (1999).
103. Huebner J, Quaas A, Krueger WA, Goldmann DA, Pier GB. Prophylactic and therapeutic efficacy of antibodies to a capsular polysaccharide shared among vancomycin-sensitive and -resistant enterococci. Infect. Immun. 68 (8), 4631-4636 (2000).
104. Palmer KL, Godfrey P, Griggs A et al. Comparative genomics of enterococci: Variation in Enterococcus faecalis, clade structure in E. faecium, and defining characteristics of E. gallinarum and E. casseliflavus. MBio 3 (1), e00318-11 (2012).
105. Pazur JH, Anderson JS, Karakawa WW. Glycans from streptococcal cell walls. Immunological and chemical properties of a new diheteroglycan from Streptococcus faecalis. J. Biol. Chem. 246 (6), 1793-1798 (1971).
106. Qin X, Galloway-Pena JR, Sillanpaa J et al. Complete genome sequence of Enterococcus faecium strain TX16 and comparative genomic analysis of Enterococcus faecium genomes. BMC Microbiol. 12, 135 (2012).
107. Singh KV, Lewis RJ, Murray BE. Importance of the epa locus of Enterococcus faecalis OG1RF in a mouse model of ascending urinary tract infection. J. Infect. Dis. 200 (3), 417-420 (2009).
108. Teng F, Singh KV, Bourgogne A, Zeng J, Murray BE. Further characterization of the epa gene cluster and Epa polysaccharides of Enterococcus faecalis. Infect. Immun. 77 (9), 3759-3767 (2009).
109. Xu Y, Singh KV, Qin X, Murray BE, Weinstock GM. Analysis of a gene cluster of Enterococcus faecalis involved in polysaccharide biosynthesis. Infect. Immun. 68 (2), 815-823 (2000).
110. Xu Y, Jiang L, Murray BE, Weinstock GM. Enterococcus faecalis antigens in human infections. Infect. Immun. 65 (10), 4207-4215 (1997).
111. Xu Y, Murray BE, Weinstock GM. A cluster of genes involved in polysaccharide biosynthesis from Enterococcus faecalis OG1RF. Infect. Immun. 66 (9), 4313-4323 (1998).
112. Schneewind O, Mihaylova-Petkov D, Model P. Cell wall sorting signals in surface proteins of gram-positive bacteria. EMBO J. 12 (12), 4803-4811 (1993).
113. Schneewind O, Fowler A, Faull KF. Structure of the cell wall anchor of surface proteins in Staphylococcus aureus. Science 268 (5207), 103-106 (1995).
114. Hendrickx AP, Willems RJ, Bonten MJ, van Schaik W. LPxTG surface proteins of enterococci. Trends Microbiol. 17 (9), 423-430 (2009).
115. Cucarella C, Solano C, Valle J, Amorena B, Lasa I, Penades Jr. Bap, a Staphylococcus aureus surface protein involved in biofilm formation. J. Bacteriol. 183 (9), 2888-2896 (2001).
116. Michel JL, Madoff LC, Olson K, Kling DE, Kasper DL, Ausubel FM. Large, identical, tandem repeating units in the C protein alpha antigen gene, bca, of group B streptococci. Proc. Natl Acad. Sci. USA 89 (21), 10060-10064 (1992).
117. Stalhammar-Carlemalm M, Stenberg L, Lindahl G. Protein rib: A novel group B streptococcal cell surface protein that confers protective immunity and is expressed by most strains causing invasive infections. J. Exp. Med. 177 (6), 1593-1603 (1993).
118. Stalhammar-Carlemalm M, Areschoug T, Larsson C, Lindahl G. The R28 protein of Streptococcus pyogenes is related to several group B streptococcal surface proteins, confers protective immunity and promotes binding to human epithelial cells. Mol. Microbiol. 33 (1), 208-219 (1999).
119. Coque TM, Willems R, Canton R, Del Campo R, Baquero F. High occurrence of esp among ampicillin-resistant and vancomycin-susceptible Enterococcus faecium clones from hospitalized patients. J. Antimicrob. Chemother. 50 (6), 1035-1038 (2002).
120. Top J, Sinnige JC, Majoor EA, Bonten MJ, Willems RJ, van Schaik W. The recombinase IntA is required for excision of esp-containing ICEEfm1 in Enterococcus faecium. J. Bacteriol. 193 (4), 1003-1006 (2011).
121. van Wamel WJ, Hendrickx AP, Bonten MJ, Top J, Posthuma G, Willems RJ. Growth condition-dependent esp expression by Enterococcus faecium affects initial adherence and biofilm formation. Infect. Immun. 75 (2), 924-931 (2007).
122. Paganelli FL, Willems RJ, Jansen P et al. Enterococcus faecium biofilm formation: Identification of major autolysin AtlAEfm, associated Acm surface localization, and AtlAEfm-independent extracellular DNA release. MBio 4 (2), e00154 (2013).
123. Paganelli FL, Willems RJ, Leavis HL Optimizing future treatment of enterococcal infections: Attacking the biofilm? Trends Microbiol. 20 (1), 40-49 (2012).
124. Heikens E, Bonten MJ, Willems RJ. Enterococcal surface protein Esp is important for biofilm formation of Enterococcus faecium E1162. J. Bacteriol. 189 (22), 8233-8240 (2007).
125. Leendertse M, Heikens E, Wijnands LM et al. Enterococcal surface protein transiently aggravates Enterococcus faecium-induced urinary tract infection in mice. J. Infect. Dis. 200 (7), 1162-1165 (2009).
126. Heikens E, Singh KV, Jacques-Palaz KD et al. Contribution of the enterococcal surface protein Esp to pathogenesis of Enterococcus faecium endocarditis. Microbes Infect. 13 (14-15), 1185-1190 (2011).
127. Heikens E, Leendertse M, Wijnands LM et al. Enterococcal surface protein Esp is not essential for cell adhesion and intestinal colonization of Enterococcus faecium in mice. BMC Microbiol. 9, 19 (2009).
128. Nallapareddy SR, Weinstock GM, Murray BE. Clinical isolates of Enterococcus faecium exhibit strain-specific collagen binding mediated by Acm, a new member of the MSCRAMM family. Mol. Microbiol. 47 (6), 1733-1747 (2003).
129. Nallapareddy SR, Sillanpaa J, Ganesh VK, Hook M, Murray BE Inhibition of Enterococcus faecium adherence to collagen by antibodies against high-affinity binding subdomains of Acm. Infect. Immun. 75 (6), 3192-3196 (2007).
130. Nallapareddy SR, Singh KV, Okhuysen PC, Murray BE. A functional collagen adhesin gene, Acm, in clinical isolates of Enterococcus faecium correlates with the recent success of this emerging nosocomial pathogen. Infect. Immun. 76 (9), 4110-4119 (2008).
131. Liu Q, Ponnuraj K, Xu Y et al. The Enterococcus faecalis MSCRAMM ACE binds its ligand by the Collagen Hug model. J. Biol. Chem. 282 (27), 19629-19637 (2007).
132. Zong Y, Xu Y, Liang X et al. A 'Collagen Hug' model for Staphylococcus aureus CNA binding to collagen. EMBO J. 24 (24), 4224-4236 (2005).
133. Nallapareddy SR, Singh KV, Murray BE. Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect. Immun. 76 (9), 4120-4128 (2008).
134. Sillanpaa J, Nallapareddy SR, Prakash VP et al. Identification and phenotypic characterization of a second collagen adhesin, Scm, and genome-based identification and analysis of 13 other predicted MSCRAMMs, including four distinct pilus loci, in Enterococcus faecium. Microbiology 154 (Pt 10), 3199-3211 (2008).
135. Sillanpää J, Prakash VP, Nallapareddy SR, Murray BE. Distribution of genes encoding MSCRAMMs and pili in clinical and natural populations of Enterococcus faecium. J. Clin. Microbiol. 47 (4), 896-901 (2009).
136. Horing S, Schutz M, Autenrieth IB, Grobner S. Lysozyme facilitates adherence of Enterococcus faecium to host cells and induction of necrotic cell death. Microbes Infect. 14 (6), 554-562 (2012).
137. Hendrickx AP, Budzik JM, Oh SY, Schneewind O. Architects at the bacterial surface-sortases and the assembly of pili with isopeptide bonds. Nat. Rev. Microbiol. 9 (3), 166-176 (2011).
138. Budzik JM, Marraffini LA, Souda P, Whitelegge JP, Faull KF, Schneewind O. Amide bonds assemble pili on the surface of bacilli. Proc. Natl Acad. Sci. USA 105 (29), 10215-10220 (2008).
139. Budzik JM, Poor CB, Faull KF, Whitelegge JP, He C, Schneewind O. Intramolecular amide bonds stabilize pili on the surface of bacilli. Proc. Natl Acad. Sci. USA 106 (47), 19992-19997 (2009).
140. Hendrickx AP, Poor CB, Jureller JE, Budzik JM, He C, Schneewind O. Isopeptide bonds of the major pilin protein BcpA influence pilus structure and bundle formation on the surface of Bacillus cereus. Mol. Microbiol. 85 (1), 152-163 (2012).
141. Kim DS, Singh KV, Nallapareddy SR et al. The fms21 (pilA)-fms20 locus encoding one of four distinct pili of Enterococcus faecium is harboured on a large transferable plasmid associated with gut colonization and virulence. J. Med. Microbiol. 59 (Pt 4), 505-507 (2010).
142. Hendrickx AP, Schapendonk CM, van Luit- Asbroek M, Bonten MJ, van Luit-Asbroek M, Willems RJ. Differential PilA pilus assembly by a hospital-acquired and a community-derived Enterococcus faecium isolate. Microbiology 156 (Pt 9), 2649-2659 (2010).
143. Sillanpaa J, Nallapareddy SR, Singh KV et al. Characterization of the ebpfm pilus-encoding operon of Enterococcus faecium and its role in biofilm formation and virulence in a murine model of urinary tract infection. Virulence 1 (4), 236-246 (2010).
144. Nallapareddy SR, Singh KV, Sillanpaa J et al. Endocarditis and biofilm-associated pili of Enterococcus faecalis. J. Clin. Invest. 116 (10), 2799-2807 (2006).
145. Nielsen HV, Guiton PS, Kline KA et al. The metal ion-dependent adhesion site motif of the Enterococcus faecalis EbpA pilin mediates pilus function in catheter-associated urinary tract infection. MBio 3 (4), e00177-12 (2012).
146. Siezen R, Boekhorst J, Muscariello L, Molenaar D, Renckens B, Kleerebezem M. Lactobacillus plantarum gene clusters encoding putative cell-surface protein complexes for carbohydrate utilization are conserved in specific Gram-positive bacteria. BMC Genomics 7, 126 (2006).
147. Brinster S, Furlan S, Serror P. C-terminal WxL domain mediates cell wall binding in Enterococcus faecalis and other gram-positive bacteria. J. Bacteriol. 189 (4), 1244-1253 (2007).
148. Solheim M, Brekke MC, Snipen LG, Willems RJ, Nes IF, Brede DA. Comparative genomic analysis reveals significant enrichment of mobile genetic elements and genes encoding surface structure-proteins in hospital-associated clonal complex 2 Enterococcus faecalis. BMC Microbiol. 11, 3 (2011).
149. Brinster S, Posteraro B, Bierne H et al. Enterococcal leucine-rich repeat-containing protein involved in virulence and host inflammatory response. Infect. Immun. 75 (9), 4463-4471 (2007).
150. Patti GJ, Kim SJ, Yu TY et al. Vancomycin and oritavancin have different modes of action in Enterococcus faecium. J. Mol. Biol. 392 (5), 1178-1191 (2009).
151. Belley A, Neesham-Grenon E, McKay G et al. Oritavancin kills stationary-phase and biofilm Staphylococcus aureus cells in vitro. Antimicrob. Agents Chemother. 53 (3), 918-925 (2009).
152. Fontana R, Ligozzi M, Pittaluga F, Satta G. Intrinsic penicillin resistance in enterococci. Microb. Drug Resist. 2 (2), 209-213 (1996).
153. Alonso JM, Taha MK. [Meningococcal vaccines: Present status and perspectives]. Therapie 60 (3), 283-286 (2005).
154. Pletz MW, Maus U, Krug N, Welte T, Lode H. Pneumococcal vaccines: Mechanism of action, impact on epidemiology and adaption of the species. Int. J. Antimicrob. Agents 32 (3), 199-206 (2008).
155. Telford JL. Bacterial genome variability and its impact on vaccine design. Cell Host Microbe 3 (6), 408-416 (2008).
156. Gilmore MS, Ferretti JJ. Microbiology. The thin line between gut commensal and pathogen. Science 299 (5615), 1999-2002 (2003).